Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Coma

3,4-methylenedioxyamphetamine has been researched along with Coma in 3 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Coma: A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Holden, R1
Jackson, MA1
Kaskey, GB1
Grange, SL1
Castro, S1
Owensby, S1
Thorpe, M1

Other Studies

3 other studies available for 3,4-methylenedioxyamphetamine and Coma

ArticleYear
Near-fatal hyponatraemic coma due to vasopressin over-secretion after "ecstasy" (3,4-MDMA)
    Lancet (London, England), 1996, Apr-13, Volume: 347, Issue:9007

    Topics: 3,4-Methylenedioxyamphetamine; Adult; Coma; Hallucinogens; Humans; Hyponatremia; Male; Serotonin Age

1996
Possible interaction between an MAOI and "ecstasy".
    The American journal of psychiatry, 1992, Volume: 149, Issue:3

    Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Coma; Delirium; Designer Drugs; Drug Interactions; Female

1992
Keeping the circle of love alive.
    Nursing, 1996, Volume: 26, Issue:9

    Topics: Adaptation, Psychological; Aged; Cerebrovascular Disorders; Coma; Family; Female; Humans; Love; Pati

1996